Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS

2.

Arrieta-Bolanos

E

,

Crivello

P

,

Shaw

BE

, et al.

In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance

.

Blood Adv

.

2018

;

2

(

14

):

1773

-

1783

.

3.

Meurer

T

,

Crivello

P

,

Metzing

M

, et al.

Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM

.

Blood

.

2021

;

137

(

7

):

923

-

928

.

4.

Arrieta-Bolanos

E

,

Crivello

P

,

He

M

, et al.

A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation

.

Blood

.

2022

;

140

(

6

):

659

-

663

.

5.

Hurley

CK

,

Woolfrey

A

,

Wang

T

, et al.

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors

.

Blood

.

2013

;

121

(

23

):

4800

-

4806

.

6.

Crivello

P

,

Arrieta-Bolanos

E

,

He

M

, et al.

Impact of the HLA immunopeptidome on survival of leukemia patients after unrelated donor transplantation

.

J Clin Oncol

.

2023

;

41

(

13

):

2416

-

2427

.

7.

Laghmouchi

A

,

Kester

MGD

,

Hoogstraten

C

, et al.

Promiscuity of peptides presented in HLA-DP molecules from different immunogenicity groups is associated with T-cell cross-reactivity

.

Front Immunol

.

2022

;

13

:

831822

.

8.

van Balen

P

,

Kester

MGD

,

de Klerk

W

, et al.

Immunopeptidome analysis of HLA-DPB1 allelic variants reveals new functional hierarchies

.

J Immunol

.

2020

;

204

(

12

):

3273

-

3282

.

9.

Meurer

T

,

Arrieta-Bolanos

E

,

Metzing

M

, et al.

Dissecting genetic control of HLA-DPB1 expression and its relation to structural mismatch models in hematopoietic stem cell transplantation

.

Front Immunol

.

2018

;

9

:

2236

.

10.

Fleischhauer

K

,

Shaw

BE

,

Gooley

T

, et al.

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study

.

Lancet Oncol

.

2012

;

13

(

4

):

366

-

374

.

11.

Petersdorf

EW

,

Bengtsson

M

,

De Santis

D

, et al.

Role of HLA-DP expression in graft-versus-host disease after unrelated donor transplantation

.

J Clin Oncol

.

2020

;

38

(

24

):

2712

-

2718

.

12.

Pidala

J

,

Lee

SJ

,

Ahn

KW

, et al.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

.

Blood

.

2014

;

124

(

16

):

2596

-

2606

.

13.

Fleischhauer

K

,

Ahn

KW

,

Wang

HL

, et al.

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation

.

Bone Marrow Transplant

.

2017

;

52

(

9

):

1280

-

1287

.

14.

Ruggeri

A

,

De Wreede

LC

,

Muller

CR

, et al.

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

.

Haematologica

.

2023

;

108

(

2

):

645

-

652

.

15.

Schone

B

,

Bergmann

S

,

Lang

K

, et al.

Predicting an HLA-DPB1 expression marker based on standard DPB1 genotyping: linkage analysis of over 32,000 samples

.

Hum Immunol

.

2018

;

79

(

1

):

20

-

27

.

16.

Petersdorf

EW

,

Malkki

M

,

O'hUigin

C

, et al.

High HLA-DP expression and graft-versus-host disease

.

N Engl J Med

.

2015

;

373

(

7

):

599

-

609

.

17.

Morishima

S

,

Shiina

T

,

Suzuki

S

, et al.

Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation

.

Blood

.

2018

;

131

(

7

):

808

-

817

.

18.

Buhler

S

,

Baldomero

H

,

Ferrari-Lacraz

S

, et al.

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

.

Blood Adv

.

2021

;

5

(

17

):

3377

-

3386

.

19.

Mytilineos

D

,

Tsamadou

C

,

Neuchel

C

, et al.

The human leukocyte antigen-DPB1 degree of compatibility is determined by its expression level and mismatch permissiveness: a German multicenter analysis

.

Front Immunol

.

2020

;

11

:

614976

.

20.

Bolanos-Meade

J

,

Hamadani

M

,

Wu

J

, et al.

Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis

.

N Engl J Med

.

2023

;

388

(

25

):

2338

-

2348

.

21.

Fleischhauer

K

.

Haplo-PtCy: adjusting the HLA barrier

.

Blood

.

2022

;

139

(

10

):

1431

-

1433

.

22.

Sorror

M

,

Storer

B

,

Sandmaier

BM

, et al.

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

.

Cancer

.

2008

;

112

(

9

):

1992

-

2001

.

23.

Saccardi

R

,

Putter

H

,

Eikema

DJ

, et al.

Benchmarking of survival outcomes following haematopoietic stem cell transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)

.

Bone Marrow Transplant

.

2023

;

58

(

6

):

659

-

666

.